Does Rallies track congressional trades in EMR?

Yes. Rallies tracks politician and congressional stock disclosures for EMR, including reported purchases, sales, dates, owners, and trade amounts when available.

Is EMR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EMR. It does not provide personalized investment advice.

EMR (Emerson Electric) Stock Analysis - Politician Trades

Emerson Electric (EMR) is a publicly traded Industrials sector company. As of May 19, 2026, EMR trades at $132.68 with a market cap of $74.52B and a P/E ratio of 0.00. EMR moved +0.35% today. Year to date, EMR is -2.65%; over the trailing twelve months it is +9.63%. Its 52-week range spans $90.06 to $165.15. Analyst consensus is buy with an average price target of $163.00. Rallies surfaces EMR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded EMR stock?

Recent politician trading activity in EMR includes disclosures from Rich McCormick, Val Hoyle, Ritchie Torres, Bruce Westerman, and Bruce Westerman. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

EMR Key Metrics

Key financial metrics for EMR
Metric	Value
Price	$132.68
Market Cap	$74.52B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.56%
52-Week High	$165.15
52-Week Low	$90.06
Volume	1.68M
Avg Volume	0
Revenue (TTM)	$18.32B
Net Income	$2.45B
Gross Margin	52.67%

Congressional Trades in EMR

Rich McCormick purchase EMR on Nov 5, 2025 (amount: $15.00K).
Val Hoyle sale EMR on Sep 23, 2025 (amount: $15.00K) for Spouse.
Ritchie Torres sale EMR on Jul 11, 2025 (amount: $15.00K).
Bruce Westerman sale EMR on Apr 21, 2025 (amount: $15.00K).
Bruce Westerman purchase EMR on Mar 3, 2025 (amount: $15.00K).

Latest EMR News

Emerson Cuts Emissions 49%, Diverts 70% Waste and Pledges $200M Education Fund — May 19, 2026
Emerson Adds Prompt-Based AI Code Generation to LabVIEW+ Suite, Available 2026 — May 13, 2026
Emerson Unveils Distributed Node-Based Data Fabric, Adds AI-Ready Enterprise Scalability — May 13, 2026
Emerson Launches AspenTech AVA AI Platform With Four Optimization Advisors — May 11, 2026
Emerson rallies 6% as Q2 margins beat and FY2026 outlook reaffirmed — May 6, 2026

Recent EMR Insider Trades

Karsanbhai Surendralal Lanca sold 5.70K (~$811.23K) on Mar 10, 2026.
LEVATICH MATTHEW S sold 1.48K (~$239.35K) on Feb 10, 2026.
Piazza Nicholas J. sold 6.70K (~$1.07M) on Feb 9, 2026.

EMR Analyst Consensus

11 analysts cover EMR: 0 strong buy, 6 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $163.00.

Common questions about EMR

Which politicians traded EMR stock?: Recent politician trading activity in EMR includes disclosures from Rich McCormick, Val Hoyle, Ritchie Torres, Bruce Westerman, and Bruce Westerman. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in EMR?: Yes. Rallies tracks politician and congressional stock disclosures for EMR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is EMR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EMR. It does not provide personalized investment advice.